LAKEWOOD, Colo.  — Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa”, “we”, “us”, or “our”), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced the appointment of Mark Capone to its Board of Directors (the “Board”), effective January 5, 2024. Dr. John Sullivan, Ph.D., Chairman of the Board […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced Matthew F. McManus has been appointed President, Diagnostics and Genomics Segment, effective January 8, 2024. Dr. McManus succeeds Kim Kelderman, who will become Bio-Techne’s Chief Executive Officer effective February 1, 2024. Dr. McManus has over two decades of experience as a senior life sciences leader, most recently serving as […]

SOUTH SAN FRANCISCO, Calif. —  Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Adam Laponis as chief financial officer. Mr. Laponis brings experience across small cap and Fortune 50 companies along with a track record of collaborating across teams to drive […]

Dr Peter Selders takes over as CEO, Matthias Altendorf new president of the Supervisory Board Endress+Hauser has completed the announced change at the top of the Group: Dr Peter Selders has taken over as CEO of the Swiss specialist for measurement technology and automation solutions. The 54-year-old holds a doctorate in physics, has been with […]

Former Fortis Life Sciences CEO and private equity executive to drive expansion into clinical end markets and accelerate strategic biopharma collaborations  SOUTH SAN FRANCISCO, Calif. – Mission Bio, a leader in single-cell multiomic solutions for precision medicine, announced the appointment of Brian Kim as Chief Executive Officer. With over two decades of experience in the life […]

While the business of Biotage continues to perform well, following consultation with the Board Tomas Blomquist will leave his role as CEO & President of Biotage AB with immediate effect. The Chairman of the Board, Torben Jørgensen, has been appointed by the Board of Directors as interim CEO while the process of recruiting a new […]

ROCKVILLE, Md. — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and innovative bioprocessing applications, is pleased to confirm the appointment of Maher Masoud as President and Chief Executive Officer of MaxCyte effective as of January 1, […]

Penny James, BioPharmaceuticals R&D Chief Operating Officer at AstraZeneca, Brings Three Decades of Expertise to Strengthen My Green Lab’s Commitment to Sustainable Science NORTHAMPTON, MA  — My Green Lab, the world’s leading nonprofit organization dedicated to improving the sustainability of scientific research, is proud to announce the appointment of Penny James to its Board of […]

InSphero, the global leader in 3D in vitro technology for drug safety and efficacy testing, is proud to announce the appointment of Paul Clémençon, MBA as the new Chief Business Officer (CBO), further strengthening its Executive team. Zürich, Switzerland — InSphero, the global leader in 3D in vitro technology for drug safety and efficacy testing, is proud to announce […]

COLUMBUS, Ohio — Mettler-Toledo International Inc. (NYSE: MTD) announced today that Robert F. Spoerry will retire and not stand for re-election to the Board of Directors at the annual meeting of shareholders on May 9th, 2024. Mr. Spoerry served Mettler-Toledo for 40 years, including as the CEO from 1993 until 2007, and Chair of the […]